Author: Christina Echegaray
Sep. 27, 2021—Vanderbilt's Meg Rush, MD, MMHC, spoke to several members of Congress recently and painted a vivid picture of the toll the virus has taken on children in Tennessee and at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Sep. 17, 2021—Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.
Sep. 15, 2021—Vanderbilt has opened a state of the art maternal fetal clinic to help expectant parents navigate the difficult decision-making process for babies at risk for or born with birth defects or abnormalities.
Sep. 2, 2021—Middle Tennessee home builder Willow Branch Homes has donated one of their new homes to raffle off in support of Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Aug. 26, 2021—Children and young adults who are obese are at greater risk for malignant thyroid nodules, according to new study from Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Jul. 22, 2021—A decade’s worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.
Jun. 29, 2021—Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Madeline Heard served as the virtual patient ambassador for the Iroquois Steeplechase on Saturday, June 26.
Jun. 15, 2021—Monroe Carell Jr. Children’s Hospital at Vanderbilt has once again been named a national leader in pediatric health care, earning the distinction as the No. 1 pediatric hospital in Tennessee, and in a new regional ranking, sharing first place in the Southeast Region, according to the latest U.S. News & World Report’s annual Best Children’s Hospital rankings.
Patient of Monroe Carell Jr. Children’s Hospital at Vanderbilt first in world to receive new investigational gene editing therapy
Jun. 3, 2021—A 9-year-old patient of Monroe Carell Jr. Children’s Hospital at Vanderbilt is the first in the world to receive an investigational gene editing therapy for Methylmalonic Acidemia (MMA), a rare genetic disorder diagnosed at birth.
Apr. 21, 2021—Zachary Warren, PhD, professor of Pediatrics, Psychiatry & Behavioral Sciences and Special Education, has been named director of the Division of Developmental Medicine in the Vanderbilt Department of Pediatrics. His appointment began April 1.